Evidence base: HIV

The latest clinical trials, guidelines and resources to help in the management of HIV.

T-lymphocyte blood cell (green) infected with HIV (Photograph: SPL)
T-lymphocyte blood cell (green) infected with HIV (Photograph: SPL)

CLINICAL TRIALS

1. The strategic management of antiretroviral therapy (SMART)4 trial confirmed that untreated HIV patients have increased HIV-related morbidity and mortality with declining CD4 counts, but also increased mortality attributed to conditions that have previously not been recognised to be HIV-related, such as non-AIDS malignancies.

This trial indicated that treatment-naive patients, or those who were not receiving treatment for the previous six months, had a risk of opportunistic infection or serious non-AIDS event of seven per 100 patient-years compared with 1.6 per 100 patient-years in the virological suppression arm.

This trial strongly supports the lifelong continuation of antiretroviral treatment and discourages 'drug holidays'.

2. AIDS Clinical Trial Group 5142 was an open label randomised trial which showed that efavirenz was potent long term at high viral loads when compared with a boosted protease inhibitor. (N Engl J Med 2008; 358: 2095-106).

Therefore the non-nucleoside analogue efavirenz remains alongside the nucleoside analogue backbone, a first choice regimen when starting antiretrovirals.


GUIDELINES

1. UK National HIV testing guidelines 2008. These guidelines emphasise that HIV is treatable and patients with HIV indicator diseases should be offered an HIV test. www.bhiva.org/documents/Guidelines/Testing/GlinesHIVTest08.pdf

2. BHIVA published and approved guidelines in 2008 www.bhiva.org


KEY TEXT

Madge S, Matthews P, Singh S et al. Management of HIV in Primary Care. Medical Foundation for AIDS and Sexual Health. (revised April 2005 and downloadable at www.medfash.org) 


CURRICULUM

The RCGP covers this topic in statement 11 Sexual Health


ONLINE

1. Health Protection Agency www.hpa.org.uk. Further epidemiology data on HIV can be found under topics AIDS/HIV.

2. Guidance on various drug interactions can be found at www.hiv-druginteractions.org
 
Contributed by Dr Charlotte Hopkins and Dr R Monica Lascar, consultants in HIV and genitourinary medicine at Whipps Cross University Hospital, London.

GP Online recommends

Evidence-based practice

Read more

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Mandatory face covering in GP practices vital as face-to-face contacts rise, warns BMA

Mandatory face covering in GP practices vital as face-to-face contacts rise, warns BMA

Face coverings should be mandatory for patients visiting GP practices amid a rapid...

How new technology can help GPs manage ENT patients

How new technology can help GPs manage ENT patients

Dr Marcelino Ruiz-Martin and Dr Ruth Chambers explain how a practice in Staffordshire...

Face-to-face GP consultations up 70% since start of lockdown

Face-to-face GP consultations up 70% since start of lockdown

Face-to-face GP consultations have risen 70% compared with the early stages of lockdown,...

PCN development undermined by lack of local autonomy, report warns

PCN development undermined by lack of local autonomy, report warns

Primary care network (PCN) development is being undermined because they lack the...

Breast pain - red flag symptoms

Breast pain - red flag symptoms

Breast pain in women and men has a variety of possible causes, from prescription...

Workload crisis looms as GPs prepare for biggest flu campaign ever and winter COVID spike

Workload crisis looms as GPs prepare for biggest flu campaign ever and winter COVID spike

GPs face a surge in workload over the coming months as the government rolls out the...